Navigation Links
Arena Pharma, Geron, Incyte, and Spectrum Pharma Under AAAResearchReports.com Microscope
Date:7/29/2013

LONDON, July 29, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Friday, July 26, 2013, shares of biotech companies ended mostly lower even as the broader market posted gains. The major movers in the industry included Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Geron Corporation (NASDAQ: GERN), Incyte Corporation (NASDAQ: INCY), and Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI). AAAResearchReports.com has released full comprehensive research on ARNA, GERN, INCY, and SPPI. These free technical analyses can be downloaded by signing up at:

http://www.aaaresearchreports.com/register/  

Shares of Arena Pharmaceuticals, Inc. fell sharply on Friday, finishing at $6.86, down 2.14% from its previous trading session's closing price. The company's shares oscillated between $6.83 and $7.01. A total of 3.01 million shares were traded, which is below the daily average volume of 5.84 million. Arena's shares have fallen by 10.91% in the last one month as compared to a loss of 0.03% in the S&P 500. A free technical analysis on ARNA available by signing up at:

http://www.AAAResearchReports.com/ARNA072913.pdf

Geron Corporation's stock fell sharply on Friday, extending its losses for the week. The company's shares oscillated between $1.38 and $1.44 before ending the day 4.17% lower at $1.38. A total of 260,089 shares were traded, which is below the daily average volume of 994,053. The company's shares fell by 6.76% last week. Nonetheless, the stock has advanced 21.05% in the last three
'/>"/>

SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SynCardia Total Artificial Heart Bridges Former Semi-Pro Arena Football Player to Heart Transplant
2. Todays Research on Incyte and Arena Pharma: Biotech Stocks Up on Drug Approvals
3. New Competitive Arena Emerges for Pharmaceutical Companies in Healthcares Changing Payment Landscape, Finds PwC Health Research Institute Study
4. Todays Technical View: AstraZeneca, GlaxoSmithKline, Keryx Biopharma, and Raptor Pharma
5. Technical Briefing: Amgen, PDL BioPharma, Questcor Pharma, and BioCryst Pharma
6. MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCalls Microscope
7. Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCalls Microscope
8. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
9. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
10. Enox Biopharma, Inc. Grants TTA LTD License To Wound Care Applications
11. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... The wet form ... of special anti-vascular endothelial growth factor agents given by injection into the eye. ... have a scientific protocol for the many millions diagnosed with it. AMD usually ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/cqsxmg/gene_therapy ... report "Gene Therapy - Technologies, Markets and Companies" ... gene therapy are difficult to estimate as there is ... marketed in China since 2004. ... The estimates are based on epidemiology of diseases to ...
(Date:9/2/2015)... September 2, 2015 Biovista Inc. ... of the 2015 BeHEARD science challenge, a global competition ... disease researchers, access to the latest life science innovations ... repositioning and pathway analytics capability to support Steven ... in the study of Niemann-Pick Disease Type A (NPA), ...
(Date:9/2/2015)... 2, 2015  Neurotech Pharmaceuticals, Inc., announced today ... multicenter Phase 2 clinical trial of NT-503 Encapsulated ... recurrent subfoveal choroidal neovascularization secondary to age related ... vascular endothelial growth factor (VEGF) receptor protein continuously ... "This landmark proof-of-concept study will evaluate NT-503 ECT ...
Breaking Biology Technology:StemCell GeneticMed Announces That It Has Started Stem Cell Treatments for Age Related Dry Macular Degeneration (AMG) 2Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4
... Partners and Versant Ventures Lead ... Transform Clinical Microbiology, MADISON, Wis., Sept. 12 OpGen, ... equity financing. The round,was led by CHL Medical Partners, Highland ... participating. In,conjunction, CHL,s Ron Lennox will become chairman of the ...
... PHOENIX, Sept. 11 ThirdBiotech,( http://www.thirdbiotech.com ), ... has begun operations in Arizona. (Logo: ... of ThirdBiotech created the group to foster,networking ... and healthcare,community throughout the state. "It,s important ...
... LAKE CITY, Sept. 11 Dynatronics,Corporation (Nasdaq: ... quarter,and fiscal year ended June 30, 2007 during ... has scheduled a conference call for investors later ... results for the quarter and fiscal year.,Those interested ...
Cached Biology Technology:OpGen Announces $23.6 Million Series A Financing 2OpGen Announces $23.6 Million Series A Financing 3
(Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
(Date:8/12/2015)... , Aug. 12, 2015  New research unveiled ... attack Android phones to steal users, fingerprints. Information ... availability of fingerprint scanners on mobile devices, making ... To secure biometrics on mobile devices, HYPR Corp. ... these convenient authentication systems with strong cryptographic security. ...
(Date:8/11/2015)... , August 11, 2015 Today, ZUK ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a prominent smartphone manufacturer in ... ZUK selected FPC1 155 for ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
... in eastern U.S.,s forests before a blight wiped it out ... landscape thanks in part to work by a University of ... TIP). Once used extensively for building, for tanning ... wildlife, and even as nutritious fodder for hogs, the American ...
... (Santa Barbara, Calif.) New approaches are needed to ... environmental threats that lie ahead in the 21st century, ... The scientists propose that global biophysical boundaries, identified ... earth system, can define a "safe planetary operating space" ...
... the groundwater table has been dubbed the "Critical Zone" because ... and nutrients necessary for life. Now an interdisciplinary team ... Southwest with the help of a five-year, $4.35 million grant ... "We think of the critical zone as being a ...
Cached Biology News:Tennessee foresters helping to return chestnuts to American forests 2Scientists outline planetary boundaries: A safe operating space for humanity 2Scientists outline planetary boundaries: A safe operating space for humanity 3UA awarded $4.35 million to study Earth's critical zone 2UA awarded $4.35 million to study Earth's critical zone 3
p230 trans Golgi Purified Anti-Human clone 15, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
... Molecular Probes intensely fluorescent and highly ... for use in a variety of ... a strong signal. Unfortunately, protein- and ... that may cause them to bind ...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
... Source: Tritirachium album Description: ... endopeptidase used in a wide range of applications ... peptide bonds mainly following the carboxyl group of ... and is classified as a serine protease. ...
Biology Products: